Ledger.Open graph →
SEC Form D · filed February 13, 2024

Tyra Biosciences, Inc

Offering
$200.0M
Sold
$200.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CARLSBAD, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Jake Simson, Ph.D · Carlsbad, CADirectorRobert More · Carlsbad, CADirectorNina Kjellson · San Diego, CADirectorGilla Kaplan, Ph.D · Carlsbad, CADirectorHiroomi Tada, M.D., Ph.D · Carlsbad, CAExecIsan Chen, M.D · Carlsbad, CADirectorDaniel Bensen · Carlsbad, CAExecAlan Fuhrman · San Diego, CAExecRehan Verjee · Carlsbad, CADirectorMelissa Mccracken, Ph.D · Carlsbad, CADirectorSid Subramony, Ph.D · Carlsbad, CADirectorTodd Harris, Ph.D · Carlsbad, CAExec · DirectorGilla Kaplan, Ph.D · Carlsbad, CADirectorJake Simson, Ph.D · Carlsbad, CADirectorRobert More · Edison, NJDirectorHiroomi Tada, M.D., Ph.D · Carlsbad, CAExecIsan Chen, M.D · Carlsbad, CADirectorDaniel Bensen · Carlsbad, CAExecNina Kjellson · Menlo Park, CADirectorAlan Fuhrman · San Diego, CAExecRehan Verjee · Carlsbad, CADirectorMelissa Mccracken, Ph.D · Carlsbad, CADirectorSid Subramony, Ph.D · Carlsbad, CADirectorTodd Harris, Ph.D · Carlsbad, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗